China’s NMPA approves Akeso’s gumokimab for plaque psoriasis

By supporting MCP, dailypoint allows hotel teams to connect guest data and tools with widely used AI assistants. Credit: Pressmaster/Shutterstock.com.



  • Akeso gumokimab China NMPA